“Transformative Research in Type 1 Diabetes”

Tune in Tomorrow, May 19, at 3:00 PM ET
Live Webcast from JDRF’s Annual Conference: “Transformative Research in Type 1 Diabetes”

A global leader in the fight against diabetes and the largest charitable funder and advocate of type 1 diabetes research worldwide, JDRF is committed to funding research to help cure, treat, and prevent the disease and its complications. JDRF funds each of these important areas of diabetes science, and three of our researchers are excited to share with you the current state of research progress.

This month’s webcast will be a live session from JDRF’s 2011 Annual Conference entitled “Transformative Research,” which will explore research that could revolutionize the way patients with type 1 diabetes think about curing, treating and preventing the disease. Topics for the session will include:



• The latest in research toward prevention of type 1 diabetes, presented by Dr. Richard Insel, JDRF’s Chief Scientific Officer. This area of the JDRF research strategy is driven to prevent the onset of type 1 diabetes with vaccines and other therapies.
• The current state of research on cure therapies for type 1 diabetes, with Dr. Julia Greenstein, JDRF’s Assistant Vice President of Cure Therapies. JDRF’s research to cure type 1 diabetes is focused on novel ways to replace or renew insulin-producing cells, and stopping the body’s own attack on those cells.
• Discoveries in treatment therapies for type 1 diabetes, presented by Dr. Aaron Kowalski, JDRF’s Assistant Vice President of Treatment Therapies. JDRF’s research to better treat patients with type 1 diabetes works with urgency to deliver new devices and therapies that optimize blood glucose control and treat diabetic complications.

So please tune in to www.jdrf.org/livewebcasts and join the discussion on Thursday, May 19, at 3:00 PM ET. A recording will be posted after the event.